Oncorus' Series A - III Round

Oncorus raised a round of funding on December 15, 2016. Investors include Astellas Venture Management.

Oncorus is an early-stage biotechnology company developing a next-generation immunotherapy platform of oncolytic viruses to treat several types of cancer, including highly malignant and aggressive can…

Articles about Oncorus' Series A - III Round: